公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2023 | Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors | DE-RUI HUANG ; BIN-CHI LIAO ; Hsu, Wei-Hsun; CHING-YAO YANG ; YEN-TING LIN ; SHANG-GIN WU ; TZU-HSIU TSAI ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; ANN-LII CHENG ; YING-CHUN SHEN | Oncology | |||
2013 | EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients | Yang S.-Y.; Yang T.-Y.; Li Y.-J.; Chen K.-C.; Liao K.-M.; Hsu K.-H.; Tsai C.-R.; Chen C.-Y.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Tsai Y.-H.; KUAN-YU CHEN ; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsiung C.A.; Shen C.-Y.; Chang G.-C.; PAN-CHYR YANG ; Chen C.-J. | International Journal of Cancer | 11 | 10 | |
2009 | EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment | Huang C.-L.; CHIH-HSIN YANG ; KUN-HUEI YEH ; Hu F.-C.; KUAN-YU CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; ANN-LII CHENG ; PAN-CHYR YANG | Lung Cancer | 43 | 36 | |
2011 | EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients | Yang S.-Y.; Yang T.-Y.; Chen K.-C.; Li Y.-J.; Hsu K.-H.; Tsai C.-R.; Chen C.-Y.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Tsai Y.-H.; KUAN-YU CHEN ; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsiung C.A.; Shen C.-Y.; Chang G.-C.; PAN-CHYR YANG ; Chen C.-J. | Clinical Cancer Research | 27 | 25 | |
2015 | EGFR mutation and lobar location of lung adenocarcinoma | Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO ; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Yang T.-Y.; Chang G.-C. | Carcinogenesis | 13 | 12 | |
2013 | EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women | KUAN-YU CHEN ; Hsiao C.-F.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; Chen Y.-M.; Huang M.-S.; Hsiung C.A.; Chen C.-J.; PAN-CHYR YANG | Carcinogenesis | 17 | 14 | |
2006 | Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer | KUAN-YU CHEN ; LI-NA LEE ; CHONG-JEN YU ; Lee Y.-C.; Kuo S.-H.; PAN-CHYR YANG | Cancer Letters | 20 | 20 | |
2018 | Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery | WEN-CHI YANG ; FU-REN XIAO ; JIN-YUAN SHIH ; CHAO-CHI HO ; YA-FANG CHEN ; Tseng H.-M.; KUAN-YU CHEN ; WEI-YU LIAO ; CHONG-JEN YU ; CHIH-HSIN YANG ; SUNG-HSIN KUO ; CHIA-HSIEN CHENG ; PAN-CHYR YANG ; FENG-MING HSU | Radiotherapy and Oncology | 22 | 21 | |
2011 | Epidermal growth factor receptor mutation status in stage i lung adenocarcinoma with different image patterns | Hsu K.-H.; Chen K.-C. ; Yang T.-Y.; Yeh Y.-C.; Chou T.-Y.; Chen H.-Y.; Tsai C.-R.; Chen C.-Y.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Tsai Y.-H.; KUAN-YU CHEN ; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsiung C.A.; Chang G.-C.; Chen C.-J.; PAN-CHYR YANG | Journal of Thoracic Oncology | 47 | 42 | |
2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | JIN-YUAN SHIH ; Gow C.-H.; CHONG-JEN YU ; CHIH-HSIN YANG ; YIH-LEONG CHANG ; Tsai M.-F.; Hsu Y.-C.; KUAN-YU CHEN ; Su W.-P.; PAN-CHYR YANG | International Journal of Cancer | 154 | 142 | |
2015 | Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer | CHUNG-YU CHEN ; JOU-WEI LIN ; JENQ-WEN HUANG ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; PAN-CHYR YANG | Clinical Lung Cancer | 11 | 10 | |
2015 | Estrogen receptor gene polymorphisms and lung adenocarcinoma risk in never-smoking women | KUAN-YU CHEN ; Hsiao C.-F.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; Chen Y.-M.; Huang M.-S.; Tsai F.-Y.; Jiang S.-S.; Chang I.-S.; Chen C.-Y.; Hsiung C.A.; Chen C.-J.; PAN-CHYR YANG | Journal of Thoracic Oncology | 21 | 14 | |
2014 | Examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus | Dong Y.-H.; JOU-WEI LIN ; Wu L.-C.; CHUNG-YU CHEN ; CHIA-HSUIN CHANG ; KUAN-YU CHEN ; Lai M.-S. | Journal of the Formosan Medical Association | 4 | 3 | |
2017 | Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer | CHUNG-YU CHEN ; Chen Y.-Y.; MIN-SHU HSIEH ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Cancer | 25 | 23 | |
2022 | Facilitating drug delivery in the central nervous system by opening the blood-cerebrospinal fluid barrier with a single low energy shockwave pulse | Kung, Yi; KUAN-YU CHEN ; Liao, Wei-Hao; Hsu, Yi-Hua; CHUEH-HUNG WU ; MING-YEN HSIAO ; ABEL PO-HAO HUANG ; WEN-SHIANG CHEN | Fluids and barriers of the CNS | 6 | 7 | |
2016 | Fanconi anemia genes in lung adenocarcinoma - A pathway-wide study on cancer susceptibility | Yang S.-Y.; Hsiung C.-N.; Li Y.-J.; Chang G.-C.; Tsai Y.-H.; KUAN-YU CHEN ; Huang M.-S.; Su W.-C.; Chen Y.-M.; Hsiung C.A.; PAN-CHYR YANG ; Chen C.-J.; Wu P.-E.; Yu J.-C.; Shen C.-Y.; Hsu H.-M. | Journal of Biomedical Science | 15 | 14 | |
2000 | Fungal empyema thoracis: An emerging clinical entity | Ko S.-C.; KUAN-YU CHEN ; PO-REN HSUEH ; KWEN-TAY LUH ; PAN-CHYR YANG | Chest | 107 | 100 | |
2011 | Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations | Wu J.-Y.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Medicine | 32 | 27 | |
2017 | Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors | Chang I.-S.; Jiang S.-S.; CHIH-HSIN YANG ; Su W.-C.; Chien L.-H.; Hsiao C.-F.; JIH-HSIANG LEE ; Chen C.-Y.; Chen C.-H.; Chang G.-C.; Wang Z.; Lo F.-Y.; KUAN-YU CHEN ; Wang W.-C.; Chen Y.-M.; Huang M.-S.; Tsai Y.-H.; Su Y.-C.; Hsieh W.-S.; Shih W.-C.; Shieh S.-H.; Yang T.-Y.; Lan Q.; Rothman N.; Chen C.-J.; Chanock S.J.; PAN-CHYR YANG ; Hsiung C.A. | American Journal of Respiratory and Critical Care Medicine | 17 | 17 | |
2012 | Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia | Hosgood III H.D.; Wang W.-C.; Hong Y.-C.; Wang J.-C.; Chen K.; Chang I.-S.; Chen C.-J.; Lu D.; Yin Z.; Wu C.; Zheng W.; Qian B.; Park J.Y.; Kim Y.H.; Chatterjee N.; Chen Y.; Chang G.-C.; Hsiao C.-F.; Yeager M.; Tsai Y.-H.; Wei H.; Kim Y.T.; Wu W.; Zhao Z.; Chow W.-H.; Zhu X.; Lo Y.-L.; Sung S.W.; KUAN-YU CHEN ; Yuenger J.; Kim J.H.; Huang L.; Chen Y.-H.; Gao Y.-T.; Kim J.H.; Huang M.-S.; Jung T.H.; Caporaso N.; Zhao X.; Huan Z.; Yu D.; Kim C.H.; Su W.-C.; Shu X.-O.; Kim I.-S.; Bassig B.; Chen Y.-M.; Cha S.I.; Tan W.; Chen H.; Yang T.-Y.; Sung J.S.; Wang C.-L.; Li X.; Park K.H.; CHONG-JEN YU ; Ryu J.-S.; Xiang Y.; Hutchinson A.; Kim J.S.; Cai Q.; Landi M.T.; Lee K.-M.; Hung J.-Y.; Park J.-Y.; Tucker M.; Lin C.-C.; Ren Y.; Perng R.-P.; Chen C.-Y.; Jin L.; Chen K.-C.; Li Y.-J.; Chiu Y.-F.; Tsai F.-Y.; PAN-CHYR YANG ; Fraumeni Jr. J.F.; Seow A.; Lin D.; Zhou B.; Chanock S.; Hsiung C.A.; Rothman N.; Lan Q. | Human Genetics | 34 | 33 |